NASDAQ:BBH VanEck Biotech ETF - BBH Price, Holdings, & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. $158.17 +0.82 (+0.52%) (As of 03/21/2023 12:00 AM ET) Add Compare Share Share Today's Range$157.47▼$158.5250-Day Range$151.32▼$164.9152-Week Range$131.12▼$170.25Volume8,036 shsAverage Volume10,899 shsMarket Capitalization$506.14 millionAssets Under Management$481.70 millionDividend Yield0.47%Net Expense Ratio0.35% ProfileChartDividendInstitutional OwnershipHeadlinesHoldingsOptions ChainShort InterestSocial Media About VanEck Biotech ETF (NASDAQ:BBH)The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Read More Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address BBH ETF News HeadlinesMarch 18, 2023 | morningstar.comVanEck Biotech ETF BBHMarch 11, 2023 | americanbankingnews.comVanEck Biotech ETF (NASDAQ:BBH) Short Interest UpdateMarch 21, 2023 | Investing Daily (Ad)How This Trader Banked A 97% Win RateDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. December 23, 2022 | msn.comVanEck Vectors Biotech ETF declares annual distribution of $0.7488November 26, 2022 | nasdaq.comBiotech Finally Getting Its Groove BackOctober 21, 2022 | seekingalpha.comIBB iShares Biotechnology ETFSeptember 7, 2022 | nasdaq.comConsolidation Case for Biotech ETF BBHAugust 25, 2022 | uk.finance.yahoo.comVanEck Biotech ETF (BBH)March 21, 2023 | Investing Daily (Ad)How This Trader Banked A 97% Win RateDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. August 17, 2022 | nasdaq.comBiotech Bounce-Back Could Be DurableSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$481.70 million Average Daily Volume$14,937.10 Discount/Premium12.84% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume2 Put Options2 Call Options1 Short Interest2,200 shs Miscellaneous Outstanding Shares3,200,000Beta0.84 Creation Unit50,000 Creation Fee$500.00 VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.52%0.45%0.49%Other Expenses0.00%0.35%0.52%0.34%0.55%Total Expense0.35%0.70%0.68%0.57%0.68%Fee Waiver0.00%-0.38%-0.56%-0.35%-0.58%Net Expense0.35%0.61%0.58%0.50%0.56% VanEck Biotech ETF (BBH) Holdings & ExposureTop 10 BBH HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 11.13%Amgen(NASDAQ:AMGN)Holding Weight: 11.13%Gilead Sciences(NASDAQ:GILD)Holding Weight: 8.44%Gilead Sciences(NASDAQ:GILD)Holding Weight: 8.44%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 6.99%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 6.99%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 5.63%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 5.63%IQVIA(NYSE:IQV)Holding Weight: 5.29%IQVIA(NYSE:IQV)Holding Weight: 5.29%BBH Sector ExposureBBH Industry ExposureFull Holdings Details Similar ETFsInvesco DWA Healthcare Momentum ETFNASDAQ:PTHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHVanEck Pharmaceutical ETFNASDAQ:PPHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBPrincipal Healthcare Innovators ETFNASDAQ:BTECInstitutional OwnershipRockefeller Capital Management L.P.Bought 230 shares on 3/6/2023Ownership: 0.370%Northwestern Mutual Wealth Management Co.Bought 1,697 shares on 2/21/2023Ownership: 0.070%Truist Financial CorpSold 814 shares on 2/17/2023Ownership: 0.083%Mogy Joel R Investment Counsel Inc.Bought 1,013 shares on 2/15/2023Ownership: 1.111%Jane Street Group LLCBought 2,153 shares on 2/15/2023Ownership: 0.068%View All Institutional Transactions BBH ETF - Frequently Asked Questions How have BBH shares performed in 2023? VanEck Biotech ETF's stock was trading at $159.74 on January 1st, 2023. Since then, BBH shares have decreased by 1.0% and is now trading at $158.17. View the best growth stocks for 2023 here. Are investors shorting VanEck Biotech ETF? VanEck Biotech ETF saw a drop in short interest in February. As of February 28th, there was short interest totaling 2,200 shares, a drop of 74.1% from the February 13th total of 8,500 shares. Based on an average daily trading volume, of 11,000 shares, the days-to-cover ratio is presently 0.2 days. View VanEck Biotech ETF's Short Interest. How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF? VanEck Biotech ETF announced an annual dividend on Friday, December 16th. Stockholders of record on Tuesday, December 20th will be paid a dividend of $0.749 per share on Friday, December 23rd. This represents a dividend yield of 0.47%. The ex-dividend date of this dividend is Monday, December 19th. This is a boost from the stock's previous annual dividend of $0.40. Read our dividend analysis for BBH. What does BBH invest in? VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $481.70 million assets under management. What stocks does VanEck Biotech ETF hold? BBH invests in 26 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Amgen (AMGN), Gilead Sciences (GILD), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Regeneron Pharmaceuticals (REGN), IQVIA (IQV) and IQVIA (IQV). What is the management fee for VanEck Biotech ETF? VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Sanofi (SNY), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX). What is VanEck Biotech ETF's stock symbol? VanEck Biotech ETF trades on the NASDAQ under the ticker symbol "BBH." Who are VanEck Biotech ETF's major shareholders? VanEck Biotech ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Morgan Stanley (2.37%), JPMorgan Chase & Co. (2.34%), LPL Financial LLC (1.56%), Bank of America Corp DE (1.24%), Mogy Joel R Investment Counsel Inc. (1.11%) and UBS Group AG (1.02%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is VanEck Biotech ETF's stock price today? One share of BBH stock can currently be purchased for approximately $158.17. How much money does VanEck Biotech ETF make? VanEck Biotech ETF (NASDAQ:BBH) has a market capitalization of $506.14 million. This page (NASDAQ:BBH) was last updated on 3/21/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.